Thursday, 17 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14409
Articles
Company
Deals
Zhonghong Pulin Partners with Shanghai Pharma for Logistics and Distribution
February 6, 2025
Company
Deals
Suzhou Jade Biomedical Secures USD 10 Million Series B Financing
February 6, 2025
Company
Deals
Worg Pharmaceuticals Raises RMB 400 Million in Series B Funding
February 6, 2025
Company
Deals
Luye Life Sciences Partners with Uzbekistan to Establish Vaccine Center
February 6, 2025
Company
Deals
Celregen Licenses Regenerative Therapy CLS001 from Japan’s Cellusion
February 6, 2025
Company
Drug
Transcenta’s First-in-Class Gremlin1 Antibody TST003 Receives FDA IND Clearance
February 6, 2025
Company
Deals
Bide Pharmatech Set for IPO on Shanghai’s STAR Market
February 6, 2025
Drug
Policy / Regulatory
NMPA Releases 58th Batch of Reference Drugs for Generic Quality Consistency Evaluation
February 6, 2025
Company
Drug
Alphamab/3DMed’s Envafolimab Gains FDA Fast-Track Status for Sarcoma Treatment
February 6, 2025
Policy / Regulatory
Guangdong Launches Free HPV Vaccination Program for School-aged Girls
February 6, 2025
Company
Drug
Suzhou Zelgen Completes Phase II Study of Jakinib for Ankylosing Spondylitis
February 6, 2025
Policy / Regulatory
Hubei Province Proposes National TCM Patent Medicine Procurement Alliance
February 6, 2025
1
2
…
1,132
1,133
1,134
1,135
1,136
…
1,200
1,201
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?